Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02189382 · ClinicalTrials.gov registry record · NA

Evaluation of the Safety and Efficacy of an Oxalate Gel or Negative Control on Dentinal Hypersensitivity

A NA study, sponsored by Procter and Gamble.

Completed
Registry status
NA
Development phase
70
Enrollment target

NCT02189382 is a NA study that has completed, run by Procter and Gamble. The registered enrollment target is 70 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02189382, a NA study, has completed, sponsored by Procter and Gamble.

COMPLETED
Registry status
NA
Development phase
70 participants
Enrollment target

Study Summary

This study will compare the safety and effectiveness of a potassium oxalate desensitizer or negative control on dentinal hypersensitivity.

Interventions

  • OTHER Water
  • DEVICE Potassium Oxalate

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2014-06
Est. Completion 2014-07
Phase NA

Sponsor

Procter and Gamble

70 total trials

What the Registry Record Tells You About NCT02189382

The ClinicalTrials.gov registry entry for NCT02189382 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Procter and Gamble, which has 70 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Water is the first listed.

NCT02189382 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02189382 about?

NCT02189382 is a clinical study titled "Evaluation of the Safety and Efficacy of an Oxalate Gel or Negative Control on Dentinal Hypersensitivity". This study will compare the safety and effectiveness of a potassium oxalate desensitizer or negative control on dentinal hypersensitivity.

What is the current status of trial NCT02189382?

This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2014-06. Estimated completion is 2014-07.

What interventions are being tested in trial NCT02189382?

The interventions under investigation include: Water (OTHER), Potassium Oxalate (DEVICE).

Who is sponsoring clinical trial NCT02189382?

This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.